David N. Cade
Level 33, 101 Miller Street
North Sydney, NSW 2060, Australia
North Sydney, NSW 2060, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Evaluation of [89Zr]Zr-girentuximab PET imaging of clear cell renal cell carcinoma in chinese patients: a Phase 1 clinical study (ZIRDOSE-CP).
Journal: EJNMMI research
Published: June 12, 2025
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry.
Journal: EJNMMI reports
Published: May 14, 2024
Histological Comparison of Kidney Tissue Following Radioembolization with Yttrium-90 Resin Microspheres and Embolization with Bland Microspheres.
Journal: Cardiovascular and interventional radiology
Published: April 15, 2016
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 24, 2016
Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.
Journal: BMC cancer
Published: February 25, 2014
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study.
Journal: BMC cancer
Published: February 24, 2014
Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer.
Journal: British journal of cancer
Published: January 06, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026